Buy this biopharmaceutical stock that can rally 25%, says RBC Capital Markets
- Posted on February 25, 2025
- By CNBC
- 4 Views

Buy this biopharmaceutical stock that can rally 25%, says RBC Capital Markets

The firm initiated coverage at an outperform rating.